SCHEMBL21040318

SCHEMBL21040318

COC(=O)c1cc(OC(C)=O)ccc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.44
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 5/20 0.44
TRIM24 O15164 1/20 0.42
TYR P14679 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
GLA P06280 2/20 0.42
F2 P00734 1/20 0.42
HPGD P15428 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
LMNA P02545 3/20 0.41
CYP3A4 P08684 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4476198 0.85 TRIM24 (0.59) KDM4EALDH1A1TRIM24TYRTRIM33
SCHEMBL23601820 0.85 TRIM24 (0.46) KDM4EALDH1A1TRIM24TYRTRIM33
SCHEMBL10457145 0.84 KDM4E (0.58) KDM4EALDH1A1HPGDLMNACYP3A4
SCHEMBL851752 0.80 ALDH1A1 (0.40) ESR2KDM4EALDH1A1GLAF2
SCHEMBL851753 0.80 ALDH1A1 (0.40) ESR2KDM4EALDH1A1GLAF2
SCHEMBL23796497 0.80 POLB (0.42) ESR2KDM4EALDH1A1HPGDCYP1A2
SCHEMBL3292760 0.79 ALDH1A1 (0.71) KDM4EALDH1A1TRIM24TYRTRIM33
SCHEMBL21994466 0.79 ACHE (0.54) ESR2KDM4EALDH1A1GLACYP1A2
SCHEMBL28750463 0.79 KDM4E (0.56) ESR2KDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL8502531 0.79 CA12 (0.61) ESR2KDM4EALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019101086-A1 HALO-ALLYLAMINE SSAO/VAP-1 INHIBITOR AND USE THEREOF 南京药捷安康生物科技有限公司 2019-05-31 WO disclosed